# Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea

> **NCT00329459** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 320 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** sumatriptan succinate/naproxen sodium
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00329459
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2016-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00329459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00329459, "Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00329459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*